During the past decade, Guangzhou Twelfth People 's Hospita conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Guangzhou Twelfth People 's Hospita" #1 sponsor was "Sun Yat-sen University" with 13 trials, followed by "Hai Li" with 2 trials sponsored, "Nanfang Hospital of Southern Medical University" with 2 trials sponsored, "China Academy of Chinese Medical Sciences" with 1 trials sponsored and "Guangzhou University of Traditional Chinese Medicine" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Guangzhou Twelfth People 's Hospita" #1 collaborator was "Guangzhou No.12 People's Hospital" with 13 trials as a collaborator, "Kaiping Central Hospital" with 11 trials as a collaborator, "First Affiliated Hospital, Sun Yat-Sen University" with 5 trials as a collaborator, "The First Affiliated Hospital of University of South China" with 3 trials as a collaborator and "First Affiliated Hospital Xi'an Jiaotong University" with 2 trials as a collaborator. Other collaborators include 70 different institutions and companies that were collaborators in the rest 77 trials.

According to Clinical.Site data, the most researched conditions in "Guangzhou Twelfth People 's Hospita" are "Hepatocellular Carcinoma" (13 trials), "Liver Failure, Acute on Chronic" (2 trials), "Acute Cerebrovascular Accidents" (1 trials), "Acute Lymphoblastic Leukemia" (1 trials) and "Acute Stroke" (1 trials). Many other conditions were trialed in "Guangzhou Twelfth People 's Hospita" in a lesser frequency.

Most popular intervention types in "Guangzhou Twelfth People 's Hospita" are "Drug" (19 trials), "Procedure" (7 trials), "Other" (3 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sorafenib" (5 trials), "Lenvatinib" (4 trials), "PD-1 antibody" (4 trials), "HAIC of FOLFOX" (3 trials) and "Hepatic arterial infusion chemotherapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Guangzhou Twelfth People 's Hospita" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Guangzhou Twelfth People 's Hospita". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Guangzhou Twelfth People 's Hospita, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Guangzhou Twelfth People 's Hospita, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".